Novavax, Inc. (NVAX) Tops Q4 EPS by 7c

Novavax, Inc. (NASDAQ: NVAX) reported Q4 EPS of $0.03, $0.07 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $5.85 million versus the consensus estimate of $6.87 million.

For earnings history and earnings-related data on Novavax, Inc. (NVAX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c